GLP-1 Partnerships Choose Health recently launched GLP-1 Health Monitoring Panels, creating a direct sales angle to endocrinology clinics, metabolic health specialists, telemedicine providers, and pharmacies seeking convenient at-home monitoring data for patients on GLP-1 receptor agonists.

Enterprise Wellness With a small but scalable product, the company can target SMBs for employee wellness programs focused on liver and metabolic health, offering at-home testing kits and lifestyle guidance as a differentiator.

Remote Testing The at-home testing model aligns with telehealth platforms and digital clinics, presenting opportunities to partner on streamlined ordering, sample collection, and rapid result delivery.

Data Driven Care Monetize data and analytics through clinician dashboards, trend reporting, and API integrations to support monitoring of GLP-1 therapy and metabolic health outcomes.

Market Expansion Rising GLP-1 adoption and metabolic health focus in the US, coupled with an Austin base and scalable tech, supports expansion into additional states and direct-to-consumer channels as demand grows.